was pro-Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study 1
暂无分享,去创建一个
Susan M. Chang | W. Yung | M. Prados | M. Mehta | P. Wen | K. Hess | H. Fine | T. Cloughesy | D. Schiff | K. Fink | L. Junck | M. Nicholas | K. Jaeckle | H. Robins | J. Kuhn | H. Greenberg